Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders

Patent No. EP2624859 (titled "Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders") was filed by Medimmune on Sep 19, 2011. The application was issued on Mar 1, 2017.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
STRAWMAN	Nov 30, 2017	D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Oct 26, 2020
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Oct 26, 2020
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Oct 21, 2020
Termination of the opposition proceedings with revocation of patent
Sep 22, 2020
Advice of delivery
Aug 14, 2020
Communication about missing advice of delivery
Jul 21, 2020
(Electronic) Receipt
Jul 21, 2020
Advice of delivery
Jul 8, 2020
Acknowledgement of a document
Jul 8, 2020
Acknowledgement of a document
Jul 8, 2020
Decision revoking the European Patent (patent proprietor)
Jul 8, 2020
Decision revoking the European patent (opponent)
Jan 27, 2020
Communication concerning surcharge and failure to observe time limit
Sep 9, 2019
Communication of bibliographic data
Sep 9, 2019
Communication to opponent concerning maintenance
Sep 9, 2019
Communication with request to file translations
Jul 24, 2019
Refund of fees
Jul 23, 2019
F3324 Closure of the appeal proceedings: withdrawal of the appeal/ application/ opposition
Jul 23, 2019
F3324 Closure of the appeal proceedings: withdrawal of the appeal/ application/ opposition
Jul 12, 2019
F3345 Forwarding of submissions to parties
Jul 9, 2019
(Electronic) Receipt
Jul 9, 2019
Composition of the board (T)
Jul 9, 2019
Letter accompanying subsequently filed items
Jul 9, 2019
Withdrawal of an appeal
May 8, 2019
F3204 Communication of the file number to the parties
Apr 29, 2019
Processing of an appeal
Apr 26, 2019
(Electronic) Receipt
Apr 26, 2019
Letter accompanying subsequently filed items
Apr 26, 2019
Notice of appeal
Mar 13, 2019
Advice of delivery
Mar 6, 2019
Advice of delivery
Mar 6, 2019
Cover sheet for fax transmission
Feb 28, 2019
Acknowledgement of a document
Feb 28, 2019
Acknowledgement of a document
Feb 28, 2019
Annex to the communication - opposition
Feb 28, 2019
Decision of the Opposition Division and instruction
Feb 28, 2019
Druckexemplar in opposition procedure
Feb 28, 2019
Grounds for the decision (Annex) - opposition
Feb 28, 2019
Interlocutory decision in opposition proceedings
Feb 28, 2019
Internal form - Opposition/addressees
Feb 28, 2019
Internal form - Opposition/addressees
Feb 28, 2019
Means of redress
Feb 28, 2019
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Feb 28, 2019
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Feb 28, 2019
Minutes of the oral proceedings (Opposition Division) - introduction of the parties
Feb 28, 2019
Provision of a copy of the minutes - opposition procedure
Feb 28, 2019
Scanned annex to a communication - opposition procedure
Jan 17, 2019
Brief communication - Opposition proceedings
Jan 17, 2019
Brief communication - Opposition proceedings
Jan 16, 2019
Information about the result of oral proceedings
Jan 11, 2019
(Electronic) Receipt
Jan 11, 2019
Any annexes (other than citation) to an opposition letter
Jan 11, 2019
Letter accompanying subsequently filed items
Jan 11, 2019
Written submission in preparation to/during oral proceedings
Jan 9, 2019
(Electronic) Receipt
Jan 9, 2019
Letter accompanying subsequently filed items
Jan 9, 2019
Request concerning the applicant/representative
Nov 22, 2018
Brief communication - Opposition proceedings
Nov 16, 2018
(Electronic) Receipt
Nov 16, 2018
Citation in opposition procedure
Nov 16, 2018
Claims
Nov 16, 2018
Claims
Nov 16, 2018
Claims
Nov 16, 2018
Letter accompanying subsequently filed items
Nov 16, 2018
Oral proceedings: reply to date proposed
Nov 14, 2018
Brief communication - Opposition proceedings
Nov 8, 2018
(Electronic) Receipt
Nov 8, 2018
Non-patent literature cited during the opposition procedure
Nov 8, 2018
Non-patent literature cited during the opposition procedure
Nov 8, 2018
Non-patent literature cited during the opposition procedure
Nov 8, 2018
Non-patent literature cited during the opposition procedure
Nov 8, 2018
Non-patent literature cited during the opposition procedure
Nov 8, 2018
Request for interpreters during oral proceedings
Nov 8, 2018
Written submission in preparation to/during oral proceedings
Aug 6, 2018
Advice of delivery
Aug 3, 2018
Advice of delivery
Aug 3, 2018
Advice of delivery
Jul 20, 2018
Advice of delivery
Jul 12, 2018
Acknowledgement of a document
Jul 12, 2018
Acknowledgement of a document
Jul 12, 2018
Annex to the communication - opposition
Jul 12, 2018
Information concerning oral proceedings
Jul 12, 2018
Preparation for oral proceedings
Jul 12, 2018
Summons to attend oral proceedings
Jul 12, 2018
Summons to attend oral proceedings
Apr 30, 2018
Brief communication - Opposition proceedings
Apr 23, 2018
(Electronic) Receipt
Apr 23, 2018
Citation in opposition procedure
Apr 23, 2018
Citation in opposition procedure
Apr 23, 2018
Claims
Apr 23, 2018
Claims
Apr 23, 2018
Letter accompanying subsequently filed items
Apr 23, 2018
Reply of the patent proprietor to the notice(s) of opposition
Dec 15, 2017
Communication of a notice of opposition and request to file observations
Dec 15, 2017
Notice of further oppositions to opponent(s)
Dec 13, 2017
Communication of a notice of opposition - first information to patent proprietor
Nov 30, 2017
(Electronic) Receipt
Nov 30, 2017
Citation in opposition procedure
Nov 30, 2017
Citation in opposition procedure
Nov 30, 2017
Citation in opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Non-patent literature cited during the opposition procedure
Nov 30, 2017
Notice of opposition
Nov 30, 2017
Notice of opposition
Nov 30, 2017
Patent document cited during the opposition procedure
Nov 30, 2017
Patent document cited during the opposition procedure
Nov 30, 2017
Patent document cited during the opposition procedure
Aug 8, 2017
Communication of amended entries concerning the representative
Aug 2, 2017
Submission concerning change of applicant's representative
Mar 1, 2017
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Feb 2, 2017
Decision to grant a European patent
Jan 13, 2017
(Electronic) Receipt
Jan 13, 2017
Filing of the translations of the claims
Jan 13, 2017
French translation of claims
Jan 13, 2017
German translation of the claims
Jan 13, 2017
Letter accompanying subsequently filed items
Sep 28, 2016
Bibliographic data of the European patent application
Sep 28, 2016
Communication about intention to grant a European patent
Sep 28, 2016
Intention to grant (signatures)
Sep 28, 2016
Text intended for grant (clean copy)
Sep 28, 2016
Text intended for grant (version for approval)
Apr 4, 2016
Communication of amended entries concerning the representative
Mar 11, 2016
(Electronic) Receipt
Mar 11, 2016
Amended claims filed after receipt of (European) search report
Mar 11, 2016
Amended claims with annotations
Mar 11, 2016
Amended description filed after receipt of (European) search report
Mar 11, 2016
Amended description with annotations
Mar 11, 2016
Letter accompanying subsequently filed items
Mar 11, 2016
Reply to communication from the Examining Division
Mar 11, 2016
Submission concerning change of applicant's representative
Jan 7, 2016
Copy of the international search report
Jan 7, 2016
Published international application - A9
Nov 23, 2015
Annex to the communication
Nov 23, 2015
Communication from the Examining Division
Aug 12, 2015
(Electronic) Receipt
Aug 12, 2015
Amended claims with annotations
Aug 12, 2015
Claims
Aug 12, 2015
Letter accompanying subsequently filed items
Aug 12, 2015
Reply to communication from the Examining Division
Jun 3, 2015
Grant of extension of time limit (examination procedure)
May 28, 2015
(Electronic) Receipt
May 28, 2015
Letter accompanying subsequently filed items
May 28, 2015
Request for extension of time limit to communication from the Examining Division
Feb 4, 2015
Annex to the communication
Feb 4, 2015
Communication from the Examining Division
Jan 29, 2015
Examination started
Jul 17, 2013
Notification on forthcoming publication of bibliographic data
May 29, 2013
Communication regarding comments on written opinion/amendment of application/payment of claims fee
May 27, 2013
Communication to designated inventor
May 27, 2013
Communication to designated inventor
May 2, 2013
(Electronic) Receipt
May 2, 2013
Amended claims filed after receipt of (European) search report
May 2, 2013
Request for entry into the European phase
Apr 23, 2013
Copy of the international preliminary report on patentability
Feb 15, 2013
Information on entry into European phase
May 10, 2012
Priority document (electronically transmitted)
Apr 12, 2012
Copy of the international search report
Apr 12, 2012
Published international application - A1
Mar 9, 2012
Written opinion of the ISA, boxes No. I to VIII
Mar 9, 2012
Written opinion of the ISA, cover sheet
Mar 9, 2012
Written opinion of the ISA, supplemental box
Feb 7, 2012
Request for correction of obvious error
Nov 14, 2011
Request for correction of obvious error
Nov 14, 2011
Request for correction of obvious error
Nov 14, 2011
Request for correction of obvious error
Sep 27, 2011
Annex
Sep 19, 2011
(Electronic) Receipt
Sep 19, 2011
Abstract
Sep 19, 2011
Claims
Sep 19, 2011
Description
Sep 19, 2011
Drawings

EP2624859

MEDIMMUNE

Application Number: EP11761051A
Filing Date: Sep 19, 2011
Status: Revoked; Oct 23, 2020
Publication Date: Mar 1, 2017
External Links: Slate, Register , Google Patents

IP Verse

Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2624859